Headline:
AMA Statement On "Test To Treat" Does Not Align Well With Patients' Interests
Publication Date:
Thursday, March 10, 2022
Primary Source:
Type:
op-ed
Format:
Newspaper (Print)
Nature of Mention:
authored
Scholar:
Research Area:
Attached Files:
Custom Description:
Cato at Liberty op-ed by Jeffrey A. Singer on the debate regarding Paxlovid for COVID-19 treatment re-printed at American Council on Science and Health: "AMA Statement On "Test To Treat" Does Not Align Well With Patients' Interests"